Direxion Nanotechnology ETF (TYNE)
Direxion Nanotechnology ETF (TYNE) reported 31 holdings in its SEC Form NPORT-P for the period ended 2023-01-31.
No stock price history for TYNE on this site yet.
SEC Form NPORT-P as filed (series S000074011), accession 0001145549-23-021203.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| Kelly CRISPR & Gene Editing Technology ETF (XDNA) | 16.21% | ||
| Global X Genomics & Biotechnology ETF (GNOM) | United States | $0.052B | 11.01% |
| ARK Genomic Revolution ETF (ARKG) | United States | $1.236B | 10.77% |
| WisdomTree BioRevolution Fund (WDNA) | United States | $0.002B | 10.34% |
| Fidelity Disruptive Medicine ETF (FMED) | United States | $0.061B | 10.22% |
| First Trust NYSE Arca Biotechnology Index Fund (FBT) | United States | $2.270B | 10.01% |
| iShares Health Innovation Active ETF (BMED) | United States | $0.010B | 9.83% |
| Invesco Dorsey Wright Healthcare Momentum ETF (PTH) | United States | $0.121B | 9.45% |
| ETFMG Treatments Testing and Advancements ETF (GERM) | 9.33% | ||
| T. Rowe Price Health Care ETF (TMED) | United States | $0.020B | 9.17% |